Home Point-of-Care Testing: the Views of the Working Group of the Dutch Association of Clinical Chemistry
Article
Licensed
Unlicensed Requires Authentication

Point-of-Care Testing: the Views of the Working Group of the Dutch Association of Clinical Chemistry

  • Hans W. Janssen , Hans Bookelman , Jan L. S. Dols , Wiveka E. Elion Gerritzen and Ries H. de Keyzer
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 37 Issue 6

Abstract

There is clearly a demand for near-patient laboratory testing. Modern technological developments support its implementation, but these are not the only preconditions that need to be satisfied in order to successfully introduce decentralized testing. In part 2 of this paper we give a definition of decentralized testing. Part 3 presents the advantages and disadvantages. This list is a summary taken from the suggested literature. Part 4 examines the formal position of the clinical chemist. Of major importance to the situation in the Netherlands are the Care Institutions Quality Act and the Individual Health Care Professions Act. Part 5 discusses professional standards. Part 6 outlines practical considerations which might support the implementation of decentralized testing. The clinical chemist should play an active role in drawing up a discussion paper for his own hospital.

:
Published Online: 2005-06-01
Published in Print: 1999-06-01

Copyright © 1999 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Meetings and Awards
  2. Are Cardiac Troponins the Myocardial Markers for the New Millenium?
  3. Leukocyte Activation Markers in Clinical Practice
  4. Hepatitis C Virus-Specific DNA Sequences in Human DNA: Differentiation by Means of Restriction Enzyme Analysis at the DNA Level of Healthy, Anti-HCV-Negative Individuals
  5. Characterization of Monoclonal Antibodies to Human Protein 1/Clara Cell 10 Kilodalton Protein
  6. Rapid Analysis of Parathion in Biological Samples Using Headspace Solid-Phase Micro-Extraction (HS-SPME) and Gas Chromatography/Mass Spectrometry (GC/MS)
  7. Semi-Automated Rapid Isoelectric Focusing of Apolipoproteins C from Human Plasma Using PhastSystem™ and Immunofixation
  8. The c-erbB-2 Oncogene Amplification by Competitive PCR in Aneuploid Cell Clones Flow Sorted from Breast Cancer Samples
  9. The Index of Individuality Is Often a Misinterpreted Quantity Characteristic
  10. Assessment of Package Inserts for Diagnostic Kits
  11. External Quality Assessment in Clinical Chemistry: Review of the Situation in Croatia with Particular Reference to Equipment
  12. Point-of-Care Testing: the Views of the Working Group of the Dutch Association of Clinical Chemistry
  13. Preliminary Evaluation of the New Hematology Analyzer COULTER® GEN•S™ in a University Hospital
  14. Use of Biochemical Markers in Acute Coronary Syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage
  15. Oxidative Stress in Skeletal Muscle. A.E. Rezuick, L. Packer, C.K. Sen. J.O. Hollosey and M.J. Jackson, editors
  16. Handbook of Lipoprotein Testing. N. Rifai, C.G. Warnick and M.H. Dominiczak, editors
  17. Erratum: Matthias Oberhoffer, Heinz Vogelsang, Stefan Rußwurm, Thomas Hartung and Konrad Reinhart. Outcome Prediction by Traditional and New Markers of Inflammation in Patients with Sepsis
Downloaded on 18.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.1999.105/html
Scroll to top button